Authors' Reply to Letter to the Editor- in Response to: Comment on Dheyab AM et al. "Long-Term Efficacy of Oral Valganciclovir in Presumed Cytomegalovirus Unilateral Hypertensive Anterior Uveitis"

被引：0

作者：

Dheyab, Abdulsalam M. ^{[1
]}

Albloushi, Abdulrahman F. ^{[1
]}

Al-Zuabi, Asma ^{[1
,3
]}

Altariqi, Sulaiman M. ^{[1
]}

Tobaigy, Mohannad F. ^{[1
]}

Al Fawaz, Abdullah ^{[1
]}

Abu El-Asrar, Ahmed ^{[1
,2
]}

机构：

[1] King Abdulaziz Univ Hosp, Dept Ophthalmol, Airport Rd,POB 245, Riyadh 11411, Saudi Arabia

[2] King Saud Univ, Coll Med, Dr Nasser Al Rashid Res Chair Ophthalmol, Riyadh, Saudi Arabia

[3] Imam Abdulrahman Bin Faisal Univ, Coll Med, Dept Ophthalmol, Dammam, Saudi Arabia

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2025年 / 33卷 / 02期

关键词：

Anterior uveitis; cytomegalovirus; glaucoma; intraocular pressure; valganciclovir;

D O I：

10.1080/09273948.2024.2389246

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

The clinical diagnosis of presumed cytomegalovirus hypertensive anterior uveitis was based on the following criteria: 1) Recurrent episodes of unilateral hypertensive anterior uveitis characterized by acute elevation of intraocular pressure, a few medium-sized or mutton-fat keratic precipitates and mild anterior chamber reaction. These findings might be associated with corneal endotheliitis and iris atrophy. 2) Posterior synechiae and vitreous involvement are typically absent. 3) Intact corneal sensation.

引用

页码：326 / 327

页数：2

共 46 条

[31] Reply to So-Ryoung Lee, Byoung-Won Park, and Jae Heon Kim's Letter to the Editor re: Christian Gratzke, Rob van Maanen, Christopher Chapple, et al. Long-term Safety and Efficacy of Combined Mirabegron and Solifenacin Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). Eur Urol 2018;74:501-9
Gratzke, Christian
Siddiqui, Emad
EUROPEAN UROLOGY, 2019, 75 (03) : E59 - E60
[32] Reply to Won Ho Kim, Hyun-Kyu Yoon, Chang Wook Jeong's Letter to Editor re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury, Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403
Bravi, Carlo A.
EUROPEAN UROLOGY, 2020, 77 (01) : E16 - E17
[33] Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017; 72: 289-92. Do the Data Violate Kaplan-Meier Assumptions?
Gandaglia, Giorgio
Fossati, Nicola
Montorsi, Francesco
Briganti, Alberto
EUROPEAN UROLOGY, 2017, 72 (02) : E31 - E31
[34] Reply to Donald Lamm, Andreas Bohle, Joan Palou, et al.'s Letter to the Editor re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247-56
Malmstrom, Per-Uno
Sylvester, Richard J.
EUROPEAN UROLOGY, 2010, 57 (02) : E10 - E11
[35] Reply to Ilker Akyol, Hasan Soydan, and Ferhat Ates' Letter to the Editor re: Nicola Nicolai, Rosalba Miceli, Andrea Necchi, et al. Retroperitoneal Lymph Node Dissection With No Adjuvant Chemotherapy in Clinical Stage I Nonseminomatous Germ Cell Tumours: Long-Term Outcome and Analysis of Risk Factors of Recurrence. Eur Urol 2010;58:912-8
Nicolai, Nicola
Miceli, Rosalba
EUROPEAN UROLOGY, 2011, 59 (04) : E21 - E22
[36] Reply to Verane Achard, Alan Dal Pra, and Thomas Zilli's Letter to the Editor re: Carlo A. Bravi, Nicola Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9
Bravi, Carlo A.
Montorsi, Francesco
Briganti, Alberto
EUROPEAN UROLOGY, 2020, 78 (06) : E223 - E224
[37] Reply to Neeraj Kumar Goyal, Manish Garg, and Apul Goel's Letter to the Editor re: Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol 2012;61:705-11
Efstathiou, Jason A.
Shipley, William U.
Zietman, Anthony L.
EUROPEAN UROLOGY, 2012, 62 (02) : E42 - E42
[38] Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7
Gandaglia, Giorgio
Fossati, Nicola
Montorsi, Francesco
Briganti, Alberto
EUROPEAN UROLOGY, 2018, 73 (05) : E131 - E132
[39] Reply to Christian Daniel Fankhauser, Lorelei A. Mucci, and Travis A. Gerke's Letter to the Editor re: Won Sik Ham, Heather J. Chalfin, Zhaoyong Feng, et al. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer. Eur Urol 2017;71:907-12
Epstein, Jonathan I.
Trock, Bruce
Han, Misop
EUROPEAN UROLOGY, 2017, 72 (01) : E11 - E12
[40] Reply to Alan Dal Pra, Stephane Supiot and Pirus Ghadjar's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7
Gandaglia, Giorgio
Fossati, Nicola
Montorsi, Francesco
Briganti, Alberto
EUROPEAN UROLOGY, 2018, 73 (02) : E36 - E37

← 1 2 3 4 5 →